Clinical Trial

Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia

Recruiting
View on ClinicalTrials.gov →
Summary
This study adopts a strategy combining basic research with clinical investigation to systematically explore the therapeutic value of cardioneuroablation in the treatment of vagally-mediated bradycardia. The study design fully considers the complexity of the scientific question and the feasibility of clinical translation. Through rigorous experimental design and standardized operational procedures, the reliability and reproducibility of the study results are ensured.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-11.
Trial Details
NCT Number NCT07468383
Lead Sponsor Beijing Anzhen Hospital
Conditions Symptomatic Bradycardia, Autonomic Nervous System Diseases
Enrollment 188 participants
Start Date 2025-08-01
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13